Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human neuronal nicotinic receptors

C Gotti1, D Fornasari, F Clementi

  • 1Department of Medical Pharmacology, University of Milan, Italy.

Progress in Neurobiology
|November 19, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same author

First Observation of the B[over ¯]_{s}^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay and Evidence for the B[over ¯]^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay.

Physical review letters·2026
Same journal

Deletion of Fbxo25 causes excessive repetitive behavior, impaired recognition memory, reduced dendritic complexity, and aberrant protein expression in mice.

Progress in neurobiology·2026
Same journal

Neuropsychiatric Disease Mechanisms and Interventions. from 22q11.2 Deletion Syndrome Experimental Studies.

Progress in neurobiology·2026
Same journal

REM sleep as a dummy-model of the world: A theoretical framework.

Progress in neurobiology·2026
Same journal

CA3 transiently modulates spatial representation in CA1.

Progress in neurobiology·2026
Same journal

Love, death, and oxytocin: In memory of Larry Young.

Progress in neurobiology·2026
Same journal

Assessing peripheral oxytocin and cortisol levels and epigenetic variations of oxytocin receptor and glucocorticoid receptor genes in school-aged preterm-born children.

Progress in neurobiology·2026
See all related articles

Neuronal nicotinic acetylcholine receptors (NAChRs) are key targets for drug therapy in CNS disorders. This review details NAChR structure, function, and subtype diversity, highlighting species differences for human therapeutic development.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Nicotine affects the central nervous system by interacting with neuronal nicotinic acetylcholine receptors (NAChRs).
  • These receptors are implicated in neurological disorders like Alzheimer's disease, schizophrenia, and epilepsy.
  • Existing knowledge of human NAChRs is incomplete, with significant differences noted compared to other species.

Purpose of the Study:

  • To review the structure and function of NAChRs.
  • To examine the molecular basis of NAChR functional diversity.
  • To summarize knowledge on NAChRs in humans and other species, including new drug classifications.

Main Methods:

  • Pharmacological and biochemical perspectives were used to analyze NAChR structure and function.

Related Experiment Videos

  • Comparative analysis of NAChRs across different species.
  • Literature review of current research on NAChR subtypes and their regulation.

    • Main Results:

    • NACHRs form a family of diverse subtypes with distinct pharmacology and physiology.
    • Significant interspecies differences exist in NAChR distribution, physiology, and pharmacology.
    • New drugs have been identified for classifying NAChR subtypes.

    Conclusions:

    • Human NACHRs are critical targets for treating central nervous system disorders.
    • Understanding species-specific NAChR characteristics is crucial for developing effective therapies.
    • Further research is needed to fully elucidate the role of NACHRs in behavior and pathology.